News
Public Comments Reveal Widespread Unity in Opposition to NIST’s March-In Rights Framework
February 5, 2024
No Comments
WTO appears close to rejecting a proposed waiver on patents for Covid diagnostics and therapies
January 31, 2024
No Comments
Iancu, Michel and Other PTAB Masters Panelists Float Ways to Make the System Better
January 30, 2024
No Comments
The March-In Drug Price Control Narrative Crumbles While Its Damage to American Innovation Grows
January 29, 2024
No Comments
Proposed ‘price’ criteria for march-in rights poses threat to U.S. innovation, critics say
January 23, 2024
No Comments
Witnesses Clash Over Potential Pros and Cons of PERA in Senate IP Subcommittee Hearing
January 23, 2024
No Comments